Kamijo R, Takeda K, Nagumo M, Konno K
1st Department of Biochemistry, School of Medicine, Showa University, Tokyo, Japan.
Biochem Biophys Res Commun. 1989 Jan 16;158(1):155-62. doi: 10.1016/s0006-291x(89)80191-3.
Human transforming growth factor-beta (TGF-beta) dose-dependently inhibited proliferation of WI-38 cells, normal human diploid fibroblasts, stimulated by tumor necrosis factor (TNF). Inhibition occurred at 1 ng/ml concentration of TGF-beta. Also, TGF-beta dose-dependently suppressed cytotoxicity of TNF against L-929 cells, murine transformed fibroblasts. The concentration of TNF required for 50% cytolysis of L-929 cells was changed from 30 ng/ml to 350 ng/ml by 10 ng/ml TGF-beta. This suppression was abolished when L-929 cells were treated with actinomycin D or cycloheximide, suggesting that TGF-beta might inhibit the action of TNF via de novo protein synthesis. This response was not due to down regulation of TNF receptors nor to alteration of the affinity of TNF for its receptor.
人转化生长因子-β(TGF-β)可剂量依赖性地抑制由肿瘤坏死因子(TNF)刺激的WI-38细胞(正常人二倍体成纤维细胞)的增殖。在TGF-β浓度为1 ng/ml时即出现抑制作用。此外,TGF-β还可剂量依赖性地抑制TNF对L-929细胞(鼠转化成纤维细胞)的细胞毒性。10 ng/ml的TGF-β可使L-929细胞发生50%细胞溶解所需的TNF浓度从30 ng/ml变为350 ng/ml。当用放线菌素D或环己酰亚胺处理L-929细胞时,这种抑制作用消失,提示TGF-β可能通过从头合成蛋白质来抑制TNF的作用。这种反应并非由于TNF受体的下调,也不是由于TNF与其受体亲和力的改变。